Partial year: Data through Q3 2025 (Sept 30). Full-year totals not yet available.
HX

Hongjiang Xu

CC Chia Tai Tianqing Pharmaceutical Group Co.: 5 patents #2 of 125Top 2%
📍 Lianyungang, CN: #3 of 62 inventorsTop 5%
Overall (2025): #23,824 of 469,880Top 6%
5
Patents 2025

Issued Patents 2025

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
12371431 Trifluoromethyl-substituted sulfonamide as BCL-2-selective inhibitor Fei Liu, Weiwei Feng, Bin Wang, Jinan Wang, Xiquan Zhang +13 more 2025-07-29
12336996 Drug combination containing TLR7 agonist Dandan Lu, Xingfeng Ge, Wei Song, Wei Shi, Ling Yang +3 more 2025-06-24
12319689 Methyl- and trifluoromethyl-containing disubstituted sulfonamide selective BCL-2 inhibitor Fei Liu, Yanlong Liu, Xiquan Zhang, Shanchun Wang, Jianqing Zhang +6 more 2025-06-03
12240811 N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition and uses thereof Yinsheng Zhang, Wangwei Ao, Yuan Li, Hui Wang, Hangzhou Shen +15 more 2025-03-04
12195468 TLR7 agonist for treating colorectal cancer and pharmaceutical combination thereof Mincheng Zhang, Ying Zhang, Wei Song, Ling Yang, Xiquan Zhang 2025-01-14